The p110α isoform is highly expressed or activated among medulloblastoma patient samples47, and several investigations have been reporting promising results for targeting PI3K signalling in the SHH-driven subgroup17–19 and the MYC-driven Group 323,48. The gene discussed is PIK3CB; the disease is medulloblastoma.